The FDA has issued a Class II device recall, identified as Z-1554-2026, for the Artelon FlexBand Dynamic Matrix (Ref: 31057). The reason for the recall is that the augmentation devices failed bacterial endotoxin testing. This recall impacts distribution globally, including extensive distribution across the United States.

Medical device manufacturers and distributors must ensure they have identified and accounted for all affected Artelon FlexBand units. Compliance officers should verify that their internal processes align with the recall procedures outlined by the FDA to manage the removal or correction of these devices. While specific compliance deadlines are not stated, prompt action is expected given the nature of the recall and potential patient safety implications.